|
PSMC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.13360000000229E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.558400E-03 |
| Normal-vs-Stage2 |
1.197020E-01 |
| Normal-vs-Stage3 |
1.196830E-01 |
| Normal-vs-Stage4 |
3.144000E-01 |
| Stage1-vs-Stage2 |
3.859800E-01 |
| Stage1-vs-Stage3 |
9.150400E-01 |
| Stage1-vs-Stage4 |
9.516000E-01 |
| Stage2-vs-Stage3 |
4.494200E-01 |
| Stage2-vs-Stage4 |
4.236000E-01 |
| Stage3-vs-Stage4 |
8.984400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356690E-03 |
| Normal-vs-AfricanAmerican |
1.751590E-02 |
| Normal-vs-Asian |
1.825230E-01 |
| Caucasian-vs-AfricanAmerican |
4.358800E-01 |
| Caucasian-vs-Asian |
1.581770E-01 |
| AfricanAmerican-vs-Asian |
4.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.019520E-03 |
| Normal-vs-Female |
1.482110E-03 |
| Male-vs-Female |
1.526620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.479570E-01 |
| Normal-vs-Extreme_Weight |
1.658490E-02 |
| Normal-vs-Obese |
1.474310E-02 |
| Normal-vs-Extreme_Obese |
8.582200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.374200E-01 |
| Normal_Weight-vs-Obese |
4.817600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.964200E-01 |
| Extreme_Weight-vs-Obese |
5.074800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.553600E-01 |
| Obese-vs-Extreme_Obese |
3.753600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.599500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.045530E-04 |
| Normal-vs-Age(61-80Yrs) |
2.793900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.354600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.031800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.552000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.417400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.538030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.150800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.928200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.19759999994695E-06 |
| Normal-VS-Type2 PRCC |
2.002600E-01 |
| Normal-VS-KIRP CIMP |
9.881800E-01 |
| Normal-VS-Unclassified PRCC |
4.547600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.648200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.393040E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.302400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.264600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.862000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.718800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.584550E-01 |
| Normal-vs-N1 |
9.490500E-02 |
| Normal-vs-N2 |
3.248000E-02 |
| N0-vs-N1 |
6.198400E-01 |
| N0-vs-N2 |
1.950030E-01 |
| N1-vs-N2 |
1.082830E-01 |
|
|
